NCT04188262View on ClinicalTrials.gov

Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 22, 2020

Primary Completion Date

April 5, 2022

Study Completion Date

May 31, 2022

Conditions
Peripheral Arterial DiseasePeripheral Vascular DiseasesCatheterization, Peripheral
Interventions
COMBINATION_PRODUCT

NVS Therapy

Combination Product: NVS Therapy which includes NVS Injection (investigational product) and the following investigational devices: NVS Delivery Catheter, NVS light Fiber, and NVS light source.

Trial Locations (4)

27606

NC Heart & Vascular Research, Raleigh

37660

Wellmont CVA Heart Institute, Kingsport

48604

Mid-Michigan Heart & Vascular Center, Saginaw

70360

Cardiovascular Institute of the South, Houma

Sponsors

Lead Sponsor

Alucent Biomedical
All Listed Sponsors
lead

Alucent Biomedical

INDUSTRY

NCT04188262 - Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I) | Biotech Hunter | Biotech Hunter